货号:A235907
同义名:
盐酸氯己定
/ Chlorhexidine (hydrochloride); NSC-185
Chlorhexidine 2HCl是一种双胍类化合物,作为抗菌药物具有局部抗菌活性。
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Chlorhexidine Dihydrochloride (CHX) has proven antimicrobial activity, excellent substantivity, low surface tension, and low cytotoxicity and genotoxicity that depend on the dose and exposed area[3]. CHX-IBU (chlorhexidine dihydrochloride - ibuprofen) loaded ISFI (in-situ forming implants) could be efficient as adjuvant to periodontal therapy for the control of infection and inflammation[4]. Moreover, CHX decreased in a concentration-dependend manner the number of attached gingival epithelial cells and PDL (periodontal ligament) fibroblasts. Rinsing with CHX may prevent or at least retard bacterial colonization on membrane exposed to the oral activity[5]. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT02169167 | Diabetes Mellitus ... 展开 >> Diabetes Complications Diabetic Neuropathies Wound Infection 收起 << | Not Applicable | Completed | - | Poland ... 展开 >> Diabetic Foot Clinic Regional Diabetic Centre, Department of Hypertension and Diabetology Gdańsk, Poland, 80-952 收起 << |
NCT00515151 | Catheterization, Central Venou... 展开 >>s Catheter-Associated Infections Bacterial Infections Bacteremia 收起 << | Phase 4 | Completed | - | Germany ... 展开 >> Institute of Environmental Medicine and Hospital Epidemiology University Medical Center Freiburg Freiburg, Germany Switzerland Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel Basel, Switzerland 收起 << |
NCT03224299 | Preoperative Skin Preparation | Phase 2 | Completed | - | United States, Montana ... 展开 >> BioScience Laboratories Bozeman, Montana, United States, 59718 BioScience Laboratories Butte, Montana, United States, 59701 收起 << |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
1.73mL 0.35mL 0.17mL |
8.64mL 1.73mL 0.86mL |
17.29mL 3.46mL 1.73mL |
CAS号 | 3697-42-5 |
分子式 | C22H32Cl4N10 |
分子量 | 578.37 |
SMILES Code | N=C(NC(NC1=CC=C(C=C1)Cl)=N)NCCCCCCNC(NC(NC2=CC=C(C=C2)Cl)=N)=N.[H]Cl.[H]Cl |
MDL No. | MFCD00068998 |
别名 | 盐酸氯己定 ;Chlorhexidine (hydrochloride); NSC-185; CHX; Chlorhexidine dihydrochloride |
运输 | 蓝冰 |
InChI Key | WJLVQTJZDCGNJN-UHFFFAOYSA-N |
Pubchem ID | 9571016 |
存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, room temperature |
溶解方案 |
DMSO: 20 mg/mL(34.58 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|